BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25066318)

  • 1. [Impact of antiviral therapy on the natural history of hepatitis C virus].
    Fernández Rodriguez CM; Gutierrez Garcia ML
    Gastroenterol Hepatol; 2014 Dec; 37(10):583-92. PubMed ID: 25066318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
    Michielsen P; Ho E; Francque S
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
    Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ
    J Gastroenterol Hepatol; 2014 Aug; 29 Suppl 1():1-9. PubMed ID: 25055928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies of hepatitis B and C.
    Chen RY; Desmond PV; Locarnini SA
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S471-81. PubMed ID: 12534781
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural history of acute and chronic hepatitis C.
    Maasoumy B; Wedemeyer H
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):401-12. PubMed ID: 23199500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral treatment for cirrhosis due to hepatitis C: a review.
    Somasundaram A; Venkataraman J
    Singapore Med J; 2012 Apr; 53(4):231-5. PubMed ID: 22511042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
    Nishiguchi S; Kubo S; Shiomi S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):600-4. PubMed ID: 15359868
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histological findings in the liver in patients with chronic hepatitis C].
    Takase K; Shiraki K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):434-8. PubMed ID: 15359838
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of antiviral therapy in the prevention of hepatocellular carcinoma.
    Franco J; Saeian K
    J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 2):S191-6. PubMed ID: 12354836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea.
    Park YH; Kim BK; Kim JK; Kim HC; Kim DY; Park JY; Han KH; Kim SU; Shin SH; Hahn KY; Ahn SH
    J Gastroenterol Hepatol; 2014 May; 29(5):1005-11. PubMed ID: 24325579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C genotype 3 disease.
    Kattakuzhy S; Levy R; Rosenthal E; Tang L; Wilson E; Kottilil S
    Hepatol Int; 2016 Nov; 10(6):861-870. PubMed ID: 27328848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C: Does Successful Treatment Alter the Natural History and Quality of Life?
    Gonzalez HC; Gordon SC
    Gastroenterol Clin North Am; 2020 Jun; 49(2):301-314. PubMed ID: 32389364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic hepatitis C: from discovery to cure].
    Li Q; Huang YX; Chen L
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):708-712. PubMed ID: 27788732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
    Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
    Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural History of Hepatitis C.
    Lingala S; Ghany MG
    Gastroenterol Clin North Am; 2015 Dec; 44(4):717-34. PubMed ID: 26600216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk of hepatocellular carcinoma after hepatitis C virus cure with direct-acting antivirals: the next challenges].
    Hamdane N; Baumert TF; Zeisel MB
    Med Sci (Paris); 2018 May; 34(5):391-394. PubMed ID: 29900836
    [No Abstract]   [Full Text] [Related]  

  • 19. Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.
    Zeisel MB; Lucifora J; Mason WS; Sureau C; Beck J; Levrero M; Kann M; Knolle PA; Benkirane M; Durantel D; Michel ML; Autran B; Cosset FL; Strick-Marchand H; Trépo C; Kao JH; Carrat F; Lacombe K; Schinazi RF; Barré-Sinoussi F; Delfraissy JF; Zoulim F
    Gut; 2015 Aug; 64(8):1314-26. PubMed ID: 25670809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus infection in children.
    Komatsu H; Inui A
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):427-50. PubMed ID: 25724218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.